You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重药控股(000950.SZ)完成收购重庆医药3.35%股权
格隆汇 12-20 21:08

格隆汇12月20日丨重药控股(000950.SZ)公布,公司于2019年11月12日、11月28日分别召开第七届董事会第二十七次会议、2019年第六次临时股东大会会议,审议通过了《关于收购重庆医药(集团)股份有限公司少数股东股权的议案》。

公司已于2019年12月20日在重庆股份转让中心办理完毕公司关于收购重庆医药(集团)股份有限公司(以下简称“重庆医药”)少数股东持有的其3.35%股权过户手续。截止本公告披露日,公司持有重庆医药4.4956亿股股份,占重庆医药总股比99.94%,重庆化医控股(集团)公司、深圳茂业(集团)股份有限公司、茂业商业股份有限公司不再持有重庆医药股份。涉及公司收购重庆医药少数股东股权事宜相关手续已全部履行完毕。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account